Advertisement

Topics

Swiss biotech AC Immune sells more shares in IPO

22:41 EDT 22 Sep 2016 | Reuters

ZURICH, Sept 23 (Reuters) - AC Immune, the Swiss biotech company working on treatments for Alzheimer's disease, boosted the size of its initial public offering by nearly a third as it priced the deal at $11 a share, the bottom end of its indicated ra...

Original Article: Swiss biotech AC Immune sells more shares in IPO

NEXT ARTICLE

More From BioPortfolio on "Swiss biotech AC Immune sells more shares in IPO"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...